LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026
A Winner Emerges in the War Against Microbes
Clinical Research v4i4

A Winner Emerges in the War Against Microbes

Man has benefited from copper’s inherent antimicrobial properties since the dawn of civilisation, yet it is only in the last 10-20 years that scientific studies ...
Continue Reading →
Cytomics: Managing Biocomplexity in Drug Development, Clinical Diagnostics, and Clinical Medicine
Clinical Research v4i4

Cytomics: Managing Biocomplexity in Drug Development, Clinical Diagnostics, and Clinical Medicine

Cytomics, the science of analysis at the cellular level, objectively accounts for functional phenotypes in the context of the entire organism. Furthermore, ...
Continue Reading →
Conducting Non-clinical Studies with Protein Biologics: Considerations in Test Article Characterisation and Method Development for Dose Formulation Analysis
Clinical Research v4i4

Conducting Non-clinical Studies with Protein Biologics: Considerations in Test Article Characterisation and Method Development for Dose Formulation Analysis

With the increase in the number of protein biologics in development, including monoclonal antibodies, the proportion of GLP studies conducted for protein test ar...
Continue Reading →
One year after the United Nations Summit on Noncommunicable Diseases (NCDs): New Opportunities and  Challenges in the Fight Against NCDs
Clinical Research v4i4

One year after the United Nations Summit on Noncommunicable Diseases (NCDs): New Opportunities and Challenges in the Fight Against NCDs

This past year has seen tremendous progress on NCDs at the global level, most notably with the adoption of a global target to reduce premature deaths from NCDs i...
Continue Reading →

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026